Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer
- PMID: 16388889
- DOI: 10.1016/j.mce.2005.11.020
Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer
Abstract
Regulation of breast cancer growth by estrogen is mediated by estrogen receptors (ER) in nuclear and extranuclear compartments. We assessed the structure and functions of extranuclear ER that initiate downstream signaling to the nucleus. ER, including full-length 66-kDa ER and a 46-kDa ER splice variant, are enriched in lipid rafts from MCF-7 cells with (MCF-7/HER-2) or without (MCF-7/PAR) HER-2 gene overexpression and co-localize with HER-1 and HER-2 growth factor receptors, as well as with lipid raft marker flotillin-2. In contrast, ER-negative MCF-7 cells do not express nuclear or lipid raft ER. ER knockdown with siRNA also elicits a marked loss of ER in MCF-7 cell rafts. In MCF-7/PAR cells, estrogen enhances ER association with membrane rafts and induces rapid phosphorylation of nuclear receptor coactivator AIB1, actions not detected in ER-negative cells. Thus, nuclear and lipid raft ER derive from the same transcript, and extranuclear ER co-localizes with HER receptors in membrane signaling domains that modulate downstream nuclear events leading to cell growth.
Similar articles
-
Progesterone receptor loss correlates with human epidermal growth factor receptor 2 overexpression in estrogen receptor-positive breast cancer.Clin Cancer Res. 2006 Feb 1;12(3 Pt 2):1013s-1018s. doi: 10.1158/1078-0432.CCR-05-2128. Clin Cancer Res. 2006. PMID: 16467118
-
Farnesol, a mevalonate pathway intermediate, stimulates MCF-7 breast cancer cell growth through farnesoid-X-receptor-mediated estrogen receptor activation.Breast Cancer Res Treat. 2008 Jan;107(1):49-61. doi: 10.1007/s10549-007-9535-6. Epub 2007 Feb 28. Breast Cancer Res Treat. 2008. PMID: 17333335
-
Acquired resistance to oestrogen deprivation: role for growth factor signalling kinases/oestrogen receptor cross-talk revealed in new MCF-7X model.Endocr Relat Cancer. 2005 Jul;12 Suppl 1:S85-97. doi: 10.1677/erc.1.01006. Endocr Relat Cancer. 2005. PMID: 16113102
-
Membrane-initiated steroid action in breast and prostate cancer.Steroids. 2008 Oct;73(9-10):953-60. doi: 10.1016/j.steroids.2007.12.009. Epub 2007 Dec 23. Steroids. 2008. PMID: 18249430 Review.
-
Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer.J Cell Physiol. 2006 Dec;209(3):645-52. doi: 10.1002/jcp.20785. J Cell Physiol. 2006. PMID: 17001676 Review.
Cited by
-
Autoantibodies Specific to ERα are Involved in Tamoxifen Resistance in Hormone Receptor Positive Breast Cancer.Cells. 2019 Jul 19;8(7):750. doi: 10.3390/cells8070750. Cells. 2019. PMID: 31331091 Free PMC article.
-
ERα, A Key Target for Cancer Therapy: A Review.Onco Targets Ther. 2020 Mar 11;13:2183-2191. doi: 10.2147/OTT.S236532. eCollection 2020. Onco Targets Ther. 2020. PMID: 32210584 Free PMC article. Review.
-
Secreted sphingomyelins modulate low mammary cancer incidence observed in certain mammals.Sci Rep. 2020 Nov 25;10(1):20580. doi: 10.1038/s41598-020-77639-1. Sci Rep. 2020. PMID: 33239740 Free PMC article.
-
Antiestrogens in combination with immune checkpoint inhibitors in breast cancer immunotherapy.J Steroid Biochem Mol Biol. 2019 Oct;193:105415. doi: 10.1016/j.jsbmb.2019.105415. Epub 2019 Jun 19. J Steroid Biochem Mol Biol. 2019. PMID: 31226312 Free PMC article.
-
Harnessing competing endocytic pathways for overcoming the tumor-blood barrier: magnetic resonance imaging and near-infrared imaging of bifunctional contrast media.Cancer Res. 2009 Jul 1;69(13):5610-7. doi: 10.1158/0008-5472.CAN-08-4967. Epub 2009 Jun 9. Cancer Res. 2009. PMID: 19509228 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous